NEVVI Medicare utilization intelligence

← back

LIN, ROBERTMD NPI 1770018665 Clinician

Medical Oncology · ALBUQUERQUE, NM

Specialty Medical Oncology — from billed Medicare claims
Trained NEW YORK MEDICAL COLLEGE — medical school, self-reported to CMS
In practice about 9 years since medical school (class of 2017, self-reported to CMS)
Location ALBUQUERQUE, NM · NPPES registered location
Active in data Billed Medicare 2023–2024 (2 consecutive years)
Scale 46 codes billed · 35,282 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20242026
NEW MEXICO ONCOLOGY HEMATOLOGY CONSULTANTS LTD
2024–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2026-04

Year: 2024 · 2023

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J0897 Injection, denosumab, 1 mg
J0185 Injection, aprepitant, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1449 Injection, eflapegrastim-xnst, 0.1 mg
J2469 Injection, palonosetron hcl, 25 mcg
J0640 Injection, leucovorin calcium, per 50 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J9190 Injection, fluorouracil, 500 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J3480 Injection, potassium chloride, per 2 meq
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96413 Administration of chemotherapy into vein, 1 hour or less
96375 Injection of additional new drug or substance into vein
J1626 Injection, granisetron hydrochloride, 100 mcg
J9045 Injection, carboplatin, 50 mg
36415 Insertion of needle into vein for collection of blood sample
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96415 Administration of chemotherapy into vein, each additional hour
96372 Injection of drug or substance under skin or into muscle
96523 Irrigation of implanted venous access drug delivery device
J1200 Injection, diphenhydramine hcl, up to 50 mg
J3490 Unclassified drugs
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96417 Administration of additional new drug or substance into vein, 1 hour or less
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J7030 Infusion, normal saline solution , 1000 cc
96361 Infusion into a vein for hydration, each additional hour
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
96416 Administration of prolonged chemotherapy into vein
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
G6012 Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev
96374 Injection of drug or substance into vein
99442 Telephone medical discussion with physician, 11-20 minutes
99441 Telephone medical discussion with physician, 5-10 minutes
96360 Infusion into a vein for hydration, 31-60 minutes

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.